Examination of the causal association between lung function and Alzheimer’s Disease: a Mendelian Randomization study

D. Higbee (Bristol, United Kingdom), R. Granell (Bristol, United Kingdom), G. Davey Smith (Bristol, United Kingdom), J. Henderson (Bristol, United Kingdom), J. Dodd (Bristol, United Kingdom)

Source: International Congress 2019 – Epidemiology, genetics, air pollution and sleep
Session: Epidemiology, genetics, air pollution and sleep
Session type: Thematic Poster
Number: 4402
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Higbee (Bristol, United Kingdom), R. Granell (Bristol, United Kingdom), G. Davey Smith (Bristol, United Kingdom), J. Henderson (Bristol, United Kingdom), J. Dodd (Bristol, United Kingdom). Examination of the causal association between lung function and Alzheimer’s Disease: a Mendelian Randomization study. 4402

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Kidney function and obstructive lung disease: a bidirectional Mendelian randomisation study
Source: Eur Respir J, 58 (6) 2100848; 10.1183/13993003.00848-2021
Year: 2021



Cardio metabolic traits and lung function: A Mendelian Randomization study
Source: International Congress 2018 – Role of omics in population studies
Year: 2018

Short telomere length and its association with risk for COPD and emphysema severity: Korean Obstructive Lung Disease (KOLD) cohort study
Source: International Congress 2017 – Markers of COPD progression
Year: 2017

Ventilatory impairments associated with Parkinson’s Disease: a systematic review and meta-analysis
Source: Virtual Congress 2020 – Pulmonary function and rehabilitation in non-respiratory disease
Year: 2020


Disease progression according to IPF phenotype
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012

CF-ABLE-UK score: Modification and validation of a clinical prediction rule for prognosis in cystic fibrosis on data from UK CF registry
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015


Comparative phenotype and BTNL2 polymorphism in familial and sporadic sarcoidosis in the French SARCFAM cohort
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014

Inflammation biomarkers and risk of pulmonary hypertension: a Mendelian randomization study
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020


Disease patterns in connective tissue disease-associated interstitial lung disease: a population based study
Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases
Year: 2019



Verification of genetic associations with Scleroderma associated Interstitial Lung Disease
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019


Lung function of patients with primary ciliary dyskinesia: A systematic review
Source: International Congress 2015 – Highlights in paediatric epidemiology: air pollution, asthma and primary ciliary dyskinesia
Year: 2015

Disease progression in IPF assessed using pulmonary function tests and functional respiratory imaging (FRI) – A pilot study
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014


Does the BTNL2 genotype influence the course of disease in Danish sarcoidosis patients?
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014

Phenotype heterogeneity in a familial "brain lung thyroid syndrome" related to a novel NKX-2.1 mutation
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

Distinguishing causation from genetic correlation in a Mendelian randomisation framework
Source: Eur Respir J, 58 (6) 2101346; 10.1183/13993003.01346-2021
Year: 2021



Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016

Physical activity and symptom burden in COPD: The Canadian Cohort Obstructive Lung Disease (CanCOLD) study
Source: Virtual Congress 2021 – Lung disease burden and management
Year: 2021


A weighted genetic risk score based on 279 signals of association with lung function predicts Chronic Obstructive Pulmonary Disease
Source: International Congress 2018 – Multiomics studies in epidemiology: what can they tell us?
Year: 2018




Disease progression patterns in COPD
Source: International Congress 2018 – New predictors of morbidity and mortality in COPD
Year: 2018


Heterogeneity in lung function of PiZZ alpha 1 antitrypsin deficiency: Impact of occupation in predicting disease severity
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014